Ana Martins Costa received an NWO Open Competition Domain Science-XS grant for the project "Development and validation of artificial red blood cells: In-air microencapsulation of a novel oxygen carrier".
Patient care worldwide depends on scarce human blood, and the testing of medical devices (e.g. oxygenators, dialyzers) still relies on human or animal blood. A scalable, universal, and long-term stable artificial blood has long been searched. Current approaches using mammalian hemoglobin and perfluorocarbon carriers suffer limited availability, adverse effects, environmental concerns, and poor production scalability.
We propose an innovative approach to develop artificial erythrocytes:
1) using commercial marine worm hemoglobin as oxygen-carrier,
2) selecting in-air microfluidics to fabricate core-shell-microcapsules that mimic erythrocytes,
3) setting medical device testing as intermediary goal, more feasible, but still with high impact to medical industry.
More recent news
Mon 5 Jan 2026Prof. Massimo Sartori gives invited talk at the 4th Nature Conference on flexible electronics, AI in healthcare in April 8-10, 2026.
Thu 11 Dec 2025Prof.dr.ir. Gabriëlle Tuijthof new chair of Department Biomechanical Engineering
Thu 13 Nov 2025ET UTQ Ceremony
Tue 11 Nov 2025Healthcare never stops — but neither does its emissions. Can we make it greener?
Fri 10 Oct 2025Two cum laude Master's graduations